Home
Conditions
Dyslipidemias

Clinical trial condition

Dyslipidemias

Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.

948 public trials 78 recruiting studies

Refine in advanced search Browse all conditions

Dyslipidemias trial results

Completed

Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population

NCT00150384

Conditions: Cardiovascular Diseases, Dyslipidemia, Dyslipidemias, +5 more
Locations: Pfizer Investigational Site Birmingham, Alabama, United States

Pfizer Investigational Site Birmingham, Alabama, United States

Pfizer Investigational Site Huntsville, Alabama, United States

Pfizer Investigational Site Little Rock, Arkansas, United States

View all 106 locations

View Trial Details

Completed

Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia

NCT00330785

Conditions: Cardiovascular Diseases, Dyslipidemia, Dyslipidemias, +5 more
Locations: Pfizer Investigational Site Calgary, Alberta, Canada

Pfizer Investigational Site Calgary, Alberta, Canada

Pfizer Investigational Site Calgary, Alberta, Canada

Pfizer Investigational Site Calgary, Alberta, Canada

View all 126 locations

View Trial Details

Completed

Caduet in an Untreated Subject Population

NCT00332761

Conditions: Cardiovascular Diseases, Dyslipidemia, Dyslipidemias, +5 more
Locations: Pfizer Investigational Site Jonesboro, Arkansas, United States

Pfizer Investigational Site Little Rock, Arkansas, United States

Pfizer Investigational Site Garden Grove, California, United States

Pfizer Investigational Site Long Beach, California, United States

View all 34 locations

View Trial Details

Completed

VDR SNPs & 25OHD Correlated With Dyslipidemia

NCT04707612

Conditions: Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +2 more
Locations: Shenzhen Center for Chronic Disease Control Shenzhen, Guangdong, China

View Trial Details

Completed

Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS)

NCT03360747

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Chylomicronemia Syndrome, +12 more
Locations: Investigative Site Montreal, Quebec, Canada

View Trial Details

Completed

Type 2 Diabetic Patients Maintained on Statin Therapy

NCT03784703

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemia Associated With Type II Diabetes Mellitus, +6 more
Locations: Tanta University Hospital Tanta, El-Gharbia, Egypt

View Trial Details

Completed

Dietary Protein and Insulin Sensitivity Study

NCT00508937

Conditions: Cardiovascular Disease, Cardiovascular Diseases, Diabetes Mellitus, +12 more
Locations: Cholesterol Research Center Berkeley, California, United States

San Francisco General Hospital San Francisco, California, United States

View Trial Details

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients

NCT01487460

Conditions: Dyslipidemia, Dyslipidemias, Healthy Volunteers, +5 more
Locations: Novartis Investigative Site Miramar, Florida, United States

View Trial Details

Completed

A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia

NCT04074551

Conditions: Cardiovascular Diseases, Dyslipidemias, Hypertension, +4 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Dietary Protein Sources and Atherogenic Dyslipidemia

NCT01427855

Conditions: Cardiovascular Disease, Cardiovascular Diseases, Dyslipidemia, +10 more
Locations: Cholesterol Research Center, Children's Hospital Research Institute Berkeley, California, United States

View Trial Details

Dyslipidemias

Dyslipidemias trial results

Related conditions